Search research articles
Contact Us
Filters
Showing results (81-90 of 111) with videos related to
Page
of 12
Sort By:
Clinical & Experimental Metastasis
|
November 14, 2018
Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center
L M Füreder, G Widhalm, B Gatterbauer, et al.
Breast Cancer Research and Treatment
|
January 22, 2010
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Ursula Wiedermann, C Wiltschke, J Jasinska, et al.
Plos One
|
August 14, 2013
Fatty acid composition at the base of aquatic food webs is influenced by habitat type and watershed land use
James H Larson, William B Richardson, Brent C Knights, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 19, 2005
Fulvestrant ('Faslodex') in pre-treated patients with advanced breast cancer: a single-centre experience
G G Steger, R Bartsch, C Wenzel, et al.
British Journal of Cancer
|
April 14, 2015
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial
F Fitzal, M Filipits, M Rudas, et al.
Epilepsy Research
|
April 1, 1996
D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures
A Rostock, C Tober, C Rundfeldt, et al.
The British Journal of Surgery
|
February 20, 2021
PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial
F Fitzal, M Filipits, C Fesl, et al.
British Journal of Cancer
|
June 1, 2013
Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series
F Zagouri, T N Sergentanis, V Koutoulidis, et al.
British Journal of Cancer
|
July 9, 2014
The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer
R Exner, Z Bago-Horvath, R Bartsch, et al.
British Journal of Cancer
|
February 21, 2013
High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
F Zagouri, Z Bago-Horvath, F Rössler, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 111) with videos related to
Sort By:
Page
of 12
Clinical & Experimental Metastasis
|
November 14, 2018
Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center
L M Füreder, G Widhalm, B Gatterbauer, et al.
Breast Cancer Research and Treatment
|
January 22, 2010
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Ursula Wiedermann, C Wiltschke, J Jasinska, et al.
Plos One
|
August 14, 2013
Fatty acid composition at the base of aquatic food webs is influenced by habitat type and watershed land use
James H Larson, William B Richardson, Brent C Knights, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 19, 2005
Fulvestrant ('Faslodex') in pre-treated patients with advanced breast cancer: a single-centre experience
G G Steger, R Bartsch, C Wenzel, et al.
British Journal of Cancer
|
April 14, 2015
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial
F Fitzal, M Filipits, M Rudas, et al.
Epilepsy Research
|
April 1, 1996
D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures
A Rostock, C Tober, C Rundfeldt, et al.
The British Journal of Surgery
|
February 20, 2021
PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial
F Fitzal, M Filipits, C Fesl, et al.
British Journal of Cancer
|
June 1, 2013
Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series
F Zagouri, T N Sergentanis, V Koutoulidis, et al.
British Journal of Cancer
|
July 9, 2014
The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer
R Exner, Z Bago-Horvath, R Bartsch, et al.
British Journal of Cancer
|
February 21, 2013
High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
F Zagouri, Z Bago-Horvath, F Rössler, et al.
Page
of 12